Description CanSino Biotech Inc. today announced a collaboration with National Research Council of Canada (NRC). As indicated in the agreement signed in Tianjin ...

Description Tianjin CanSino Biotechnology Inc. and the Aeras Global TB Global Foundation (Aeras) (CanSino) have reached a collaborative agreement in Beijing office of Bill and Melinda Gates Foundation...

Description CanSino GMP pilot production base was inaugurated in the Biopharm Park, West District, TEDA. The ceremony was hosted by CanSino Biotech Inc. and Tianjin Joint Academy of Biotechnology and Medicine ...

Description Today, CanSinotech submitted Clinical Trial Application (CTA) of “ACW135Y Meningococcal Conjugate Vaccine” to China Food and Drug Administration.

Description CanSinotech submitted Clinical Trial Application (CTA) of “AC Meningococcal Conjugate Vaccine” to China Food and Drug Administration..

Description CanSino Biotech Inc. won the title of “Key Overseas Chinese Entrepreneurial Team”. CanSino’s Chairman & CEO, Dr. Xuefeng Yu, today received the award certificate from Ms Haifeng Li...

Description CanSinotech submitted Clinical Trial Application (CTA) of “Diphtheria and Tetanus Toxoids and Component Pertussis Vaccine Adsorbed” to China Food and Drug Administration.

Description The Chinese Academy of Military Medical Sciences (AMMS) announced today that an Ebola vaccine (jointly developed by its Bioengineering Institute and ..

Description On February 3-4, 2015, a team led by the Qualified Person (QP) of an EU pharmaceutical enterprise conducted a two-day GMP audit of CanSino..

Description October 30, 2015, Tianjin CanSino Biotechnology Inc. (CanSino) celebrated the ground breaking of its vaccine manufacturing facilities well as the contract ...